Company logo

ESTA - Establishment Labs Holdings Inc.

NASDAQ -> Healthcare -> Medical Devices
Alajuela, Costa Rica
Type: Equity

ESTA price evolution
ESTA
(in millions $) 31 Jan 2024 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $40.03 $52.19 $90.18 $42.85
Short term investments
Net receivables $46.92 $54.69 $51.4 $41.05
Inventory $79.47 $67.94 $56.37 $46.14
Total current assets $174.9 $186.72 $209.02 $142.04
Long term investments
Property, plant & equipment $80.59 $76.2 $70.02 $61.05
Goodwill & intangible assets $8.45 $6.17 $4.69 $4.83
Total noncurrent assets $93.74 $83.81 $76.28 $67.32
Total investments
Total assets $268.64 $270.53 $285.3 $209.36
Current liabilities
Accounts payable $41.62 $28.93 $24.36 $20.25
Deferred revenue
Short long term debt
Total current liabilities $57.15 $50.3 $43.27 $41.47
Long term debt $191.45 $188.24 $185.16 $182.06
Total noncurrent liabilities $193.1 $189.74 $187.15 $183.88
Total debt $191.45 $188.24 $185.16 $182.06
Total liabilities $250.25 $240.05 $230.43 $225.35
Shareholders' equity
Retained earnings -$360.1 -$339.55 -$310.28 -$293.54
Other shareholder equity $1.96 $1.95 $1.81 $2.31
Total shareholder equity $18.39 $30.49 $54.87 -$16
(in millions $) 31 Jan 2024 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $40.03 $66.36 $53.41 $84.52
Short term investments
Net receivables $46.92 $36.82 $24.44 $19.13
Inventory $79.47 $36.58 $28.41 $23.21
Total current assets $174.9 $149.9 $113.27 $132.3
Long term investments
Property, plant & equipment $80.59 $54.79 $20.86 $18.81
Goodwill & intangible assets $8.45 $5.07 $4.84 $4.61
Total noncurrent assets $93.74 $61.16 $26.26 $24.09
Total investments
Total assets $268.64 $211.06 $139.53 $156.39
Current liabilities
Accounts payable $41.62 $20.03 $14.47 $9.72
Deferred revenue
Short long term debt
Total current liabilities $57.15 $38.96 $31.89 $25.9
Long term debt $191.45 $175.46 $53.81 $51.76
Total noncurrent liabilities $193.1 $180.29 $56.9 $55.53
Total debt $191.45 $178.66 $53.81 $51.76
Total liabilities $250.25 $219.25 $88.79 $81.43
Shareholders' equity
Retained earnings -$360.1 -$281.59 -$206.38 -$165.25
Other shareholder equity $1.96 $2.71 $3.66 $2.87
Total shareholder equity $18.39 -$8.19 $50.74 $74.96
(in millions $) 31 Jan 2024 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $38.51 $48.56 $46.52
Cost of revenue $12.45 $18.3 $16.45
Gross Profit $26.05 $30.26 $30.08
Operating activities
Research & development $7.13 $6.95 $6.53
Selling, general & administrative $39.96 $37.03 $31.71
Total operating expenses $47.09 $43.97 $38.24
Operating income -$21.04 -$13.71 -$8.16
Income from continuing operations
EBIT -$24.93 -$12.2 -$7.36
Income tax expense $0.67 $0.93 $0.83
Interest expense $3.68 $3.62 $3.76
Net income
Net income -$29.27 -$16.75 -$11.94
Income (for common shares) -$29.27 -$16.75 -$11.94
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $165.15 $161.7 $126.68 $84.68
Cost of revenue $58.17 $55.1 $41.28 $32.17
Gross Profit $106.98 $106.59 $85.4 $52.5
Operating activities
Research & development $26.43 $20.27 $18.32 $13.79
Selling, general & administrative $145.57 $125.98 $92.23 $66.63
Total operating expenses $172 $146.25 $110.54 $80.42
Operating income -$65.03 -$39.66 -$25.14 -$27.92
Income from continuing operations
EBIT -$63.19 -$61.06 -$30.65 -$28.64
Income tax expense -$0.08 $2.38 $1.43 $0.1
Interest expense $15.39 $11.76 $9.06 $9.37
Net income
Net income -$78.5 -$75.21 -$41.14 -$38.12
Income (for common shares) -$78.5 -$75.21 -$41.14 -$38.12
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income -$20.54 -$29.27 -$16.75 -$11.94
Operating activities
Depreciation $1.4 $1.24 $1.13 $1.11
Business acquisitions & disposals
Stock-based compensation $3.39 $4.04 $3.62 $3.32
Total cash flows from operations -$8.15 -$31.51 -$28.24 -$20.61
Investing activities
Capital expenditures -$3.66 -$6.36 -$8.97 -$4.23
Investments
Total cash flows from investing -$4.62 -$6.6 -$9.05 -$4.28
Financing activities
Dividends paid
Sale and purchase of stock $0.1 $0.59 $84.75 $1.27
Net borrowings $0.03 -$0.03
Total cash flows from financing $0.07 $0.49 $84.49 $1.18
Effect of exchange rate $0.55 -$0.37 $0.13 $0.2
Change in cash and equivalents -$12.15 -$37.99 $47.34 -$23.51
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$78.5 -$75.21 -$41.14 -$38.12
Operating activities
Depreciation $4.88 $4.34 $4.12 $3.71
Business acquisitions & disposals -$0.53 -$0.43 -$1.65
Stock-based compensation $14.37 $13.35 $10.41 $5.72
Total cash flows from operations -$88.51 -$52.17 -$27.53 -$12.51
Investing activities
Capital expenditures -$23.22 -$32.77 -$5.28 -$2.42
Investments
Total cash flows from investing -$24.55 -$34.79 -$7.16 -$5.56
Financing activities
Dividends paid
Sale and purchase of stock $86.71 $3.87 $4.58 $65.1
Net borrowings $96.39 -$0.17 -$0.28
Total cash flows from financing $86.23 $100.25 $4.05 $64.67
Effect of exchange rate $0.51 -$0.36 -$0.47 $0.27
Change in cash and equivalents -$26.32 $12.94 -$31.11 $46.87
Fundamentals
Market cap $1.32B
Enterprise value $1.48B
Shares outstanding 26.09M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio 80.59
Book/Share 0.63
Cash/Share 1.53
EPS N/A
ROA N/A
ROE N/A
Debt/Equity 13.60
Net debt/EBITDA N/A
Current ratio 3.06
Quick ratio 1.67